* Alector Inc ALEC.OQ reported a quarterly adjusted loss
of 40
cents per share for the quarter ended in June, lower than the
same quarter last year, when the company reported EPS of 2
cents. The mean expectation of ten analysts for the quarter was
for a loss of 50 cents per share. Wall Street expected
results to range from -60 cents to -44 cents per share.
* Revenue fell 73.2% to $15.08 million from a year ago;
analysts
expected $14.40 million.
* Alector Inc's reported EPS for the quarter was a loss
of 40
cents.
* The company reported a quarterly loss of $38.68 million.
* Alector Inc shares had risen by 11.5% this quarter and
lost 36.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 5.1%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Alector Inc is
$11.00
This summary was machine generated from LSEG data August 8 at
01:18 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.50 -0.40 Beat
Mar. 31 2024 -0.51 -0.38 Beat
Dec. 31 2023 -0.77 -0.49 Beat
Sep. 30 2023 -0.66 -0.53 Beat